An atomic-level snapshot of a respiratory syncytial virus protein bound to a human antibody represents a leap toward developing a vaccine for a common — and sometimes very serious — childhood disease.
An atomic-level snapshot of a respiratory syncytial virus protein bound to a human antibody represents a leap toward developing a vaccine for a common — and sometimes very serious — childhood disease.